Thrivent Financial for Lutherans’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.69M | Sell |
|
|||||
|
2024
Q3 | $2.24M | Buy |
|
|||||
|
2024
Q2 | $2.55M | Buy |
|
|||||
|
2024
Q1 | $2.13M | Sell |
|
|||||
|
2023
Q4 | $2.37M | Buy |
|
|||||
|
2023
Q3 | $1.53M | Sell |
|
|||||
|
2023
Q2 | $2.74M | Sell |
|
|||||
|
2023
Q1 | $2.23M | Sell |
|
|||||
|
2022
Q4 | $3.2M | Buy |
|
|||||
|
2022
Q3 | $1.65M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $733K | Sell |
|
|||||
|
2021
Q4 | $3.4M | Buy |
|
|||||
|
2021
Q3 | $209K | Sell |
|
|||||
|
2021
Q2 | $640K | Buy |
|
|||||
|
2021
Q1 | $315K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|